Could a patient with a mother having blood type AB be at risk for von Willebrand disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Type and Von Willebrand Disease Risk Assessment

A patient with a mother having blood type AB cannot be at risk for von Willebrand disease based on blood type alone, as von Willebrand disease is not directly linked to blood type inheritance patterns.

Understanding Von Willebrand Disease (VWD)

Von Willebrand Disease is the most common inherited bleeding disorder that affects both males and females equally 1. The condition results from defects in the von Willebrand factor (VWF) glycoprotein, which can be either quantitative (Types 1 and 3) or qualitative (Type 2) 2.

Key Facts About VWD:

  • VWD is inherited in an autosomal pattern (not linked to blood type)
  • It affects approximately 1 in 100 women 3
  • Most common symptom in women is menorrhagia (heavy menstrual bleeding)
  • 5-20% of women with menorrhagia have undiagnosed VWD 3

Diagnostic Approach for VWD

The diagnosis of VWD requires a comprehensive evaluation that includes:

  1. Standardized bleeding assessment tool (BAT) to objectively quantify bleeding history 4
  2. First-line laboratory tests:
    • Complete blood count (CBC) with platelet count
    • Activated partial thromboplastin time (aPTT)
    • Prothrombin time (PT)
    • VWF assays (VWF antigen, VWF activity) 4
  3. Family history assessment - nearly all clinicians (98%) include this in initial bleeding assessment 5

Important Diagnostic Considerations:

  • No single laboratory test can definitively screen for VWD 4
  • Testing may need to be repeated up to 3 times to ensure reliable results 5
  • VWF is an acute phase reactant, so levels can vary in response to clinical status 5

Blood Type and VWD Relationship

While blood type does influence VWF levels, it is not a determinant of VWD inheritance:

  • People with blood type O have approximately 25% less VWF than those with non-O blood groups 6
  • Despite this association, ABO blood group-specific reference ranges are not recommended for VWD diagnosis 5
  • VWD is inherited in an autosomal pattern, not linked to blood type inheritance

Clinical Implications

For a patient whose mother has blood type AB:

  • The mother's blood type does not increase the patient's risk for VWD
  • VWD risk should be assessed based on:
    • Personal bleeding history (using standardized BAT)
    • Family history of bleeding disorders (not just blood type)
    • Laboratory testing of VWF levels and function

Common Pitfalls to Avoid

  1. Misattributing bleeding risk to blood type alone - While blood type O is associated with lower VWF levels, VWD is determined by specific genetic mutations in the VWF gene 1

  2. Relying solely on a single VWF level measurement - VWF levels can fluctuate due to various factors including stress, inflammation, pregnancy, and hormonal status 4

  3. Overlooking other causes of bleeding symptoms - Consider other conditions like platelet disorders, hypermobility syndromes (assessed in only 55% of patients), or iron deficiency (which should be routinely checked) 5

  4. Failing to consult with a hematologist - Patients with suspected bleeding disorders should be referred to a hemophilia treatment center or hematologist with expertise in bleeding disorders for definitive diagnosis 3

In conclusion, a patient's risk for VWD is not determined by their mother's blood type AB, but rather by specific genetic mutations affecting VWF quantity or function that should be evaluated through appropriate clinical and laboratory assessment.

References

Research

von Willebrand disease.

Nature reviews. Disease primers, 2024

Research

Von Willebrand Disease: Current Status of Diagnosis and Management.

Hematology/oncology clinics of North America, 2021

Guideline

Management of Von Willebrand Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.